Jean Luc Pretet

Summary

Country: France

Publications

  1. ncbi Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study
    Jean Luc Pretet
    EA3181, IFR133, CHU Besancon, Besancon, France
    Int J Cancer 122:428-32. 2008
  2. ncbi Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study
    Jean Luc Pretet
    EA3181, IFR133, CHU Besancon, France
    Int J Cancer 122:424-7. 2008
  3. ncbi Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV)
    Francois Aubin
    Service de Dermatologie, Hospital University Saint Jacques, Besancon, France
    Clin Infect Dis 47:610-5. 2008
  4. ncbi Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study
    Jean Luc Pretet
    EA3181, IFR133, Universite de Franche Comte, Besancon, France
    Gynecol Oncol 110:179-84. 2008
  5. ncbi Novaprep(®) Vial Test is a suitable liquid-based cytology medium for high risk human papillomavirus testing by Hybrid Capture 2
    Jean Luc Pretet
    Univ Franche Comte, EA3181, Laboratoire de Biologie Cellulaire et Moleculaire, IFR133, Besancon, France
    J Clin Virol 49:286-9. 2010
  6. ncbi A multiplex SNaPshot assay as a rapid method for detecting KRAS and BRAF mutations in advanced colorectal cancers
    Sandrine Magnin
    Platform of Molecular Biology of Cancers, University Hospital of Besancon, Besancon, France
    J Mol Diagn 13:485-92. 2011
  7. ncbi Sodium butyrate with UCN-01 has marked antitumour activity against cervical cancer cells
    Anne Zélie Decrion-Barthod
    Franche Comte University, EA 3181, IFR 133, University Hospital, Besancon, France
    Anticancer Res 30:4049-61. 2010
  8. ncbi Detection of alpha- and beta-human papillomavirus (HPV) in cutaneous melanoma: a matched and controlled study using specific multiplex PCR combined with DNA microarray primer extension
    Jean Baptiste Ruer
    Universite de Franche Comte, EA3181, IFR133, Besancon, France
    Exp Dermatol 18:857-62. 2009
  9. ncbi E6 and E7 proteins from different beta-papillomaviruses types do not interfere in UVB-induced apoptosis of HaCaT keratinocytes
    Jean Sébastien Guerrini
    EA 3181, IFR 133, Universite de Franche Comte, Besancon, France
    Exp Dermatol 20:71-3. 2011
  10. ncbi TP53 polymorphism at exon 4 in caucasian women from eastern France: lack of correlation with HPV status and grade of cervical precancerous lesions
    Olivier Humbey
    Faculte de Medecine et de Pharmacie, Institut d Etude et de Transfert de Gènes, Besancon, France
    Eur J Obstet Gynecol Reprod Biol 103:60-4. 2002

Collaborators

  • Didier Riethmuller
  • Francois Aubin
  • X Carcopino
  • Massimo Tommasino
  • P Pradat
  • Antonio Marchini
  • Christiane Mougin
  • Anne Zélie Decrion-Barthod
  • Bernadette Kantelip
  • Sandrine Magnin
  • Jean Sébastien Guerrini
  • Sophie Launay
  • Jean Baptiste Ruer
  • Magali Nicolier
  • Maelle Saunier
  • Olivier Humbey
  • Alice Baraquin
  • Erika Viel
  • Veronique Bouvard
  • Marthe Bigand
  • Benoît Girardo
  • Severine Valmary-Degano
  • Christophe Borg
  • Christophe Ferrand
  • Angel Alonso
  • Evelyne Oswald
  • Jean Rommelaere
  • Magalie Nicolier
  • Marie Laure Plissonnier
  • Matthieu Bosset
  • Line Pépin
  • Chrystelle Vidal
  • Tarik Gheit
  • Jenny Briolat
  • Sylvain Monnier-Benoit
  • Frédéric Mauny
  • Elisabeth Schwarz
  • Veronique Dalstein
  • Sandrine Cairey-Remonnay
  • Estelle Seilles
  • Thierry Fest

Detail Information

Publications14

  1. ncbi Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study
    Jean Luc Pretet
    EA3181, IFR133, CHU Besancon, Besancon, France
    Int J Cancer 122:428-32. 2008
    ..Given the high HPV 16/18 prevalence and taking into account possible production of crossneutralizing antibodies against other HPV types, HPV 16/18 L1 VLP vaccination would be expected to significantly reduce the burden of ICC in France...
  2. ncbi Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study
    Jean Luc Pretet
    EA3181, IFR133, CHU Besancon, France
    Int J Cancer 122:424-7. 2008
    ..With an HPV 16 and 18 prevalence of 64%, HPV 16/18 L1 VLP vaccines would be expected to significantly reduce the burden associated with the management and treatment of CIN 2/3 in France...
  3. ncbi Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV)
    Francois Aubin
    Service de Dermatologie, Hospital University Saint Jacques, Besancon, France
    Clin Infect Dis 47:610-5. 2008
    ....
  4. ncbi Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDiTH III study
    Jean Luc Pretet
    EA3181, IFR133, Universite de Franche Comte, Besancon, France
    Gynecol Oncol 110:179-84. 2008
    ....
  5. ncbi Novaprep(®) Vial Test is a suitable liquid-based cytology medium for high risk human papillomavirus testing by Hybrid Capture 2
    Jean Luc Pretet
    Univ Franche Comte, EA3181, Laboratoire de Biologie Cellulaire et Moleculaire, IFR133, Besancon, France
    J Clin Virol 49:286-9. 2010
    ..The Novaprep(®) Vial Test (NVT) (Novacyt, Vélizy-Villacoublay, France) is a new device dedicated to LBC which permits an automated cell spreading over slides and an automated cell sampling for molecular analyses...
  6. ncbi A multiplex SNaPshot assay as a rapid method for detecting KRAS and BRAF mutations in advanced colorectal cancers
    Sandrine Magnin
    Platform of Molecular Biology of Cancers, University Hospital of Besancon, Besancon, France
    J Mol Diagn 13:485-92. 2011
    ..In conclusion, our newly designed multiplex SNaPshot assay is a fast, inexpensive, sensitive, and robust technique for molecular diagnostic practices and patient selection...
  7. ncbi Sodium butyrate with UCN-01 has marked antitumour activity against cervical cancer cells
    Anne Zélie Decrion-Barthod
    Franche Comte University, EA 3181, IFR 133, University Hospital, Besancon, France
    Anticancer Res 30:4049-61. 2010
    ..The effect of combining sodium butyrate (NaB), a histone deacetylase inhibitor, and 7-hydroxy-staurosporine (UCN-01) on cytotoxicity in human cervical carcinoma cells was evaluated...
  8. ncbi Detection of alpha- and beta-human papillomavirus (HPV) in cutaneous melanoma: a matched and controlled study using specific multiplex PCR combined with DNA microarray primer extension
    Jean Baptiste Ruer
    Universite de Franche Comte, EA3181, IFR133, Besancon, France
    Exp Dermatol 18:857-62. 2009
    ..Furthermore, specific HPV types, such as a-HPV16 and beta-HPV species 2 may be involved in a sub-group of melanoma...
  9. ncbi E6 and E7 proteins from different beta-papillomaviruses types do not interfere in UVB-induced apoptosis of HaCaT keratinocytes
    Jean Sébastien Guerrini
    EA 3181, IFR 133, Universite de Franche Comte, Besancon, France
    Exp Dermatol 20:71-3. 2011
    ..Our data suggest that the expression of E6 and E7 exert different modulatory effects on UVB-induced apoptosis according to beta-HPV types and to the cellular genetic context...
  10. ncbi TP53 polymorphism at exon 4 in caucasian women from eastern France: lack of correlation with HPV status and grade of cervical precancerous lesions
    Olivier Humbey
    Faculte de Medecine et de Pharmacie, Institut d Etude et de Transfert de Gènes, Besancon, France
    Eur J Obstet Gynecol Reprod Biol 103:60-4. 2002
    ..To investigate the codon 72 TP53 polymorphism in women from eastern France with normal or abnormal cervical cytology...
  11. ncbi [Vaccination against human papillomavirus infections]
    Jean Luc Pretet
    EA3181, IFR 133, Universite de Franche Comte, Laboratoire de Biologie Cellulaire et Moleculaire, CHU Jean Minjoz, 25030 Besancon
    Rev Prat 56:1914-8. 2006
    ....
  12. ncbi High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women
    Jean Luc Pretet
    Laboratoire de Biologie Cellulaire et Moleculaire, EA3181 et IFR 133, Centre Hospitalier Universitaire J Minjoz, boulevard A Fleming, 25030 Besancon Cedex, France
    J Clin Virol 31:140-7. 2004
    ..HCI assay, well suited for routine HR-HPV screening, is not especially dedicated for quantitative use. However, we have recently shown that women with high viral loads assessed by HCII were at increased risk of cervical precancer...
  13. ncbi Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma
    Maelle Saunier
    Laboratoire de Biologie Cellulaire et Moleculaire, IFR 133, Universite de Franche Comte, Centre Hospitalier Universitaire, boulevard A Fleming, 25030 Besancon Cedex, France
    J Clin Microbiol 46:3678-85. 2008
    ..Therefore, these assays would be useful in addition to routine HPV testing to more accurately identify women with (pre)cancerous lesions...
  14. ncbi Spatiotemporal activation of caspase-dependent and -independent pathways in staurosporine-induced apoptosis of p53wt and p53mt human cervical carcinoma cells
    Magali Nicolier
    CHU Jean Minjoz, EA 3181, IFR 133, Universite de Franche Comte, UFR Médecine et Pharmacie, Besancon, France
    Biol Cell 101:455-67. 2009
    ..Here, we have studied events linked to the mitochondrial apoptotic pathway...